Crystal structure of the xhNup93-Nb4i VHH antibody
Guttler, T., Colom, M.S., Gorlich, D.To be published.
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
5-Nup93 inhibitory VHH antibody | 127 | Vicugna pacos | Mutation(s): 0  | ||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 2 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
PEG Query on PEG | C [auth A] | DI(HYDROXYETHYL)ETHER C4 H10 O3 MTHSVFCYNBDYFN-UHFFFAOYSA-N | |||
EDO Query on EDO | B [auth A] | 1,2-ETHANEDIOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 26.877 | α = 90 |
b = 42.105 | β = 93.055 |
c = 44.946 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
PHASER | phasing |
XDS | data reduction |
XSCALE | data scaling |
Funding Organization | Location | Grant Number |
---|---|---|
Max Planck Society | Germany | -- |
Boehringer Ingelheim Fonds (BIF) | Germany | -- |